1. Targeted cutting-edge technology : Slc12a8 is a gene encoding NMN transporter with a critical role in regulating intestinal NAD+ metabolism. Longity’s advanced bioavailabilitytechnology targets directly the uptake of NMN in the small intestine where NMN’s transporter is particularly expressed. This proprietary delivery system enables a greater bioavailability and a higher absorption level, increasing Longity’s efficacy.
2. Tested: Longity NMN-C is Self-GRAS in accordance with stringent US FDA regulatory guidelines. It is manufacture in cGMP-certified facilities in Europe. Every NMN-C® batch is evaluated for purity, and impurities.
3. Safe: NMN-C® is used in in-human trials, meaning it meets clinical levels of safety, purity and quality. With 11 clinical trials underway, NMN-C® is the most extensive in-human NMN research program to date.
4. Hight Tolerance: An OECD 408 toxicology study – the first of its kind to be undertaken on Nicotinamide Mononucleotide NMN –demonstrated NMN-C® has a NOAEL tolerance level 3x higher than Nicotinamide Riboside NR and almost 7x higher than Nicotinamide NAM.
5. Natural: Formulated only with vegan, non-GMO, gluten-free, sugar-free ingredients.
